Stephen Gowing MD, PhD, FRCSC

General and Thoracic Surgeon, Advanced Foregut & Thoracic Endoscopy, Third Space Endoscopist

[Stephen Gowing MD, PhD, FRCSC @Stephen_Gowing]

https://t.co/qfDiToqAqL

TLR-4 and STING agonists within lipid bilayer nanoparticles (“Super adjuvant NPs”) co-injected with tumor specific antigens or tumor cell lysates facilitate a robust anti-cancer response.

@LFerri123 @JonathanCools @DoctorJSpicer

[Lung Cancer Europe @LungCancerEu]

‼️ BREAKTHROUGH in lung cancer monitoring.

A new Cell study from @TheCrick & @uclcancer shows ultrasensitive blood tests can detect traces of #lungcancer returning long before scans do - giving doctors an early warning & a chance to act sooner.

This could change how early-stage lung cancer is followed up & treated.
But the science is moving faster than access. Across Europe, people still wait years for new diagnostics & treatments.

Everyone deserves the chance to benefit from innovation, wherever they live.

https://t.co/SN4TgyUjzX #LCSM

[Jonathan Spicer MD PhD @DoctorJSpicer]

Wow!

[Michael Jain @MichaelDJain]

Wrote a commentary with @JonathanCools on an interesting finding that cancer patients have long term immune deficits despite curing their cancer! When do these deficits start? Before the cancer starts? Once the tumor grows? Lots of interesting Qs. https://t.co/Sm2CDLCLx0

[Pulmonology Advisor @PulmAdvisor]

Point-of-care ultrasound-guided #thoracic (POCUS-THOR) biopsies performed in an outpatient clinic are safe and have high #diagnostic accuracy.

@VGupta_MD @Stephen_Gowing @biniamkidaneMD
https://t.co/Nds7GYM2o9

[Stephen Gowing MD, PhD, FRCSC @Stephen_Gowing]

@JamieTankel @LFerri123 @MarkarSheraz @ElliotServaisMD @MagnusNsurgonc Non-operative, close follow up with imaging and endoscopy (EGD/EUS). Given PS0 could consider adjuvant therapy on clinical trial following resection. Could also consider RFA of gastric conduit for residual areas of LGD.

[Lorenzo Ferri MD PhD @LFerri123]

So excited to see this paper on the stromal changes driving Barrett’s Esophagus progression to Cancer. A Herculean effort effort integrating scRNASeq/CODEX/ECM proteomics.

Concerted changes in Epithelium and Stroma: a multi-scale, multi-omics... https://t.co/XodEJJGPR0

[Biniam Kidane @biniamkidaneMD]

Join us July 16 at 8-9am EST
Looking forward to illuminating discussions, including organ-preserving therapy in #esophageal #cancer !
Debate on SANO: is it the holy grail or just a passing mirage?

https://t.co/YrY1APXT6N

@ElliotServaisMD @Daniela_Molena @BrianLouie4 @KatherineGrayMD @ISDE_net @foregut_journal @ThoracicsCanada @SocSurgOnc @OGAAudit

[Lung Cancer Europe @LungCancerEu]

🚨 #Lungcancer survival has more than doubled.

New real-world data from France shows 3-year survival for lung adenocarcinoma rose from 16.3% (2000) to 38.6% (2020) driven by earlier diagnosis & targeted treatment.

This is what progress looks like. But it must reach everyone who needs it.

🔗 @NEJMEvidence June 2025
https://t.co/dKMo9xApKK

#LCSM

[Stephen Gowing MD, PhD, FRCSC @Stephen_Gowing]

@binance HODL

[Stephen Gowing MD, PhD, FRCSC @Stephen_Gowing]

@EM_RESUS Airway emergency (ABCs). Pharyngeal tumor obstructing upper airway. Transfer to OR for emerg fiberoptic intubation and tracheostomy. Call anesthesia and ENT or thoracic surgery. If patient unstable/hypoxic emergent cricothyroidotomy. Have Heliox available and O2 adjuncts

[Steven D Wexner MD, PhD @SWexner]

The minimum number of lymph node retrieval in gastric cancer patients ... https://t.co/BO4YSC42Dk @SurgJournal

[Shanda Blackmon, MD, MPH @ShandaBlackmon]

Complex Esophageal Reconstruction for patients who need #esophagealReplacement as seen in the @annalsthorsurg https://t.co/cGDgHophd0

[Stephen Gowing MD, PhD, FRCSC @Stephen_Gowing]

@ElliotServaisMD @MarkarSheraz Esophagectomy leak rates are realistically minimum 5-10%. I would have trouble believing a <2% esophagectomy leak rate.

[Stephen Gowing MD, PhD, FRCSC @Stephen_Gowing]

@DouglasAdlerMD I like to have a post stent CXR for my patients, that way the ED can screen for migration if issues arise.

[Stephen Gowing MD, PhD, FRCSC @Stephen_Gowing]

@DouglasAdlerMD An easy way to screen for stent migration.

[Stephen Gowing MD, PhD, FRCSC @Stephen_Gowing]

@LindaMThoracic @tssmn @GenThorSurgClub Agree. For esophageal and GEJ adenocarcinomas CROSS is the light neoadjuvant therapy for those who cannot tolerate FLOT.

[Stephen Gowing MD, PhD, FRCSC @Stephen_Gowing]

https://t.co/YJGDZ5V3uU
@LFerri123 @biniamkidaneMD @JonathanCools

Perioperative Durva for gastric and GEJ adenocarcinoma.

[Stephen Gowing MD, PhD, FRCSC @Stephen_Gowing]

@OGdukeneurosurg And left humerus ORIF

[Stephen Gowing MD, PhD, FRCSC @Stephen_Gowing]

@OGdukeneurosurg Rib plating for fractures